BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 37239435)

  • 21. Interplay between microRNAs and the epigenetic machinery: an intricate network.
    Iorio MV; Piovan C; Croce CM
    Biochim Biophys Acta; 2010; 1799(10-12):694-701. PubMed ID: 20493980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy.
    Karimzadeh MR; Pourdavoud P; Ehtesham N; Qadbeigi M; Asl MM; Alani B; Mosallaei M; Pakzad B
    Cancer Gene Ther; 2021 Apr; 28(3-4):157-174. PubMed ID: 32773776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA methylation and microRNA dysregulation in cancer.
    Suzuki H; Maruyama R; Yamamoto E; Kai M
    Mol Oncol; 2012 Dec; 6(6):567-78. PubMed ID: 22902148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
    Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
    Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic regulation by DNA methylation and miRNA molecules in cancer.
    Holubekova V; Mendelova A; Jasek K; Mersakova S; Zubor P; Lasabova Z
    Future Oncol; 2017 Oct; 13(25):2217-2222. PubMed ID: 28976205
    [No Abstract]   [Full Text] [Related]  

  • 26. Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy.
    Zhang MY; Calin GA; Yuen KS; Jin DY; Chim CS
    Clin Epigenetics; 2020 Oct; 12(1):150. PubMed ID: 33076962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.
    Baer C; Claus R; Frenzel LP; Zucknick M; Park YJ; Gu L; Weichenhan D; Fischer M; Pallasch CP; Herpel E; Rehli M; Byrd JC; Wendtner CM; Plass C
    Cancer Res; 2012 Aug; 72(15):3775-85. PubMed ID: 22710432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies.
    Wang LQ; Liang R; Chim CS
    Expert Rev Mol Diagn; 2012 Sep; 12(7):755-65. PubMed ID: 23153241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coordinated Actions of MicroRNAs with other Epigenetic Factors Regulate Skeletal Muscle Development and Adaptation.
    Bianchi M; Renzini A; Adamo S; Moresi V
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA mediated network and DNA methylation in colorectal cancer.
    Li BQ; Yu H; Wang Z; Ding GH; Liu L
    Protein Pept Lett; 2013 Mar; 20(3):352-63. PubMed ID: 22591477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetics and microRNAs.
    Chuang JC; Jones PA
    Pediatr Res; 2007 May; 61(5 Pt 2):24R-29R. PubMed ID: 17413852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The crosstalk between miRNAs and signaling pathways in human cancers: Potential therapeutic implications.
    Shekhar R; Kumari S; Vergish S; Tripathi P
    Int Rev Cell Mol Biol; 2024; 386():133-165. PubMed ID: 38782498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic cell-associated miRNAs are modulated via chromatin remodeling in response to different environments.
    Mei S; Liu Y; Bao Y; Zhang Y; Min S; Liu Y; Huang Y; Yuan X; Feng Y; Shi J; Yang R
    PLoS One; 2014; 9(4):e90231. PubMed ID: 24699235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic regulation of DNA repair genes and implications for tumor therapy.
    Christmann M; Kaina B
    Mutat Res Rev Mutat Res; 2019; 780():15-28. PubMed ID: 31395346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetically regulated microRNAs in Alzheimer's disease.
    Van den Hove DL; Kompotis K; Lardenoije R; Kenis G; Mill J; Steinbusch HW; Lesch KP; Fitzsimons CP; De Strooper B; Rutten BP
    Neurobiol Aging; 2014 Apr; 35(4):731-45. PubMed ID: 24238656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative analysis of epi-miRNA expression levels in local/locally advanced and metastatic prostate cancer patients.
    Gurbuz V; Kiliccioglu I; Dikmen AU; Bilen CY; Sozen S; Konac E
    Gene; 2020 Oct; 758():144963. PubMed ID: 32683077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic regulation of microRNA expression in colorectal cancer.
    Bandres E; Agirre X; Bitarte N; Ramirez N; Zarate R; Roman-Gomez J; Prosper F; Garcia-Foncillas J
    Int J Cancer; 2009 Dec; 125(11):2737-43. PubMed ID: 19521961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.
    Wiklund ED; Gao S; Hulf T; Sibbritt T; Nair S; Costea DE; Villadsen SB; Bakholdt V; Bramsen JB; Sørensen JA; Krogdahl A; Clark SJ; Kjems J
    PLoS One; 2011; 6(11):e27840. PubMed ID: 22132151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic Alterations of Heat Shock Proteins (HSPs) in Cancer.
    Ban HS; Han TS; Hur K; Cho HS
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31557887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia.
    Baer C; Oakes CC; Ruppert AS; Claus R; Kim-Wanner SZ; Mertens D; Zenz T; Stilgenbauer S; Byrd JC; Plass C
    Int J Cancer; 2015 Sep; 137(6):1352-61. PubMed ID: 25704289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.